Saturday, November 23, 2024
Home Authors Posts by Editor / Curator

Editor / Curator

928 POSTS 0 COMMENTS
candida auris, citius pharma, biotech stock review
Biotech News

Citius Pharma’s (CTXR) Mino-Lok® Highly Efficacious in Rapidly Eradicating Candida auris.

Editor / Curator -
Regoxidine, biotech stock review
Biotech News

Rogaine® Competitor Regoxidine™ Expected to Launch Second Half, 2019.

Editor / Curator -
Internet News

Making the TASE and Israeli Stocks Sound Sexy Once Again.

Editor / Curator -
Internet Stock Review
All News

MySizeID (MYSZ) Widget now on Shopify’s (SHOP) Site Provides Personalized, Efficient...

Editor / Curator -
Biotech News

3M to Acquire Wound Care Technology Co., Acelity for $6.7 Billion.

Editor / Curator -
video
All News

Can MySize (MYSZ) Solve the Massive eCommerce ‘Returns’ Problem?

Editor / Curator -
internet stock review
Traveltech

How Uber Changed Transportation Forever.

Editor / Curator -
All News

Facebook Set Aside $3 Billion For A Penalty. Then It Grew...

Editor / Curator -
Internet Stock Review
Stand Down.

Stand Down: Does Uber’s Valuation Make Sense?

Editor / Curator -
hotel communication network
Internet News

Kevin Bidner’s Hotel Communication Network.

Editor / Curator -
1...848586...93Page 85 of 93

Latest article

Nine Page Summary Report on GeoVax (GOVX)

2024 Watch List Editor / Curator -
This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier...

GeoVax (GOVX) Provides First Half 2024 Business Update.

2024 Watch List Editor / Curator -
Award of BARDA Project NextGen contract represents a significant milestone event; Total value...

Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.

All News Editor / Curator -
Can You Imagine Selling Solgenix at $2.00 yesterday. And to be honest, news wasn't all that big - such...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.